Pharmaceuticals in Russia: a high-growth market mainly benefiting Western laboratories (until now)

Russian market valued at USD 24 billion in 2013, dominated by sales of generic and OTC drugs. High potential market poised to rise from 14th largest in the world in 2007 to 8th by 2017. High pace of growth this decade-three times global growth- with a combination of positive factors at the outset.

Russian pharmaceutical sector caught between its deteriorating trade balance and the government's desire for more national laboratories to emerge.